December 19, 2000

The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The product consists of carbamazepine particles coated with a single hydrophobic layer and is in a disintegrating tablet form.

22

December 19, 2000

09/292,609

April 15, 1999

424/468   424/469 424/470 424/475 424/482 514/777 514/778 514/781 514/784 514/960

A61K   9/16   (20060101)   A61K   9/20   (20060101)  

424/468   424/469   424/470   424/465   424/475   424/482  

	7438927 - Methods of treatment using a gastric retained gabapentin dosage - Owned by Depomed, Inc. (Menlo Park, CA) A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
	7612112 - Methods of treatment using a gastric retained gabapentin dosage - Owned by Depomed, Inc. (Menlo Park, CA) A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.